Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Degludec vs Detemir in Pregnant Women with T1D
NCT03377699Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 2017
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 15
01
Overview
A Phase 3 trial of insulin degludec in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Nov 2017; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03377699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03377699.